Financings in Brief: Heartstream
This article was originally published in The Gray Sheet
Executive SummaryHeartstream: Adopts stockholder rights plan "to secure for stockholders the long term value of their investment and to protect stockholders from coercive takeover attempts," the company announces. Rights under the plan become effective if a person or group acquires 15% or more of Heartstream's common stock...
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.